News

Amgen said that Xgeva is a fully human monoclonal antibody that binds to RANK Ligand, a protein essential for the formation, function and survival of osteoclasts (the cells

BMS and Pfizer said that the study was stopped early based on the recommendation of an independent Data Monitoring Committee (DMC). There was clear evidence of a clinically

The study, conducted by Intercell’s collaborator, a subsidiary of Merck, was designed to evaluate the safety and immunogenicity of V710 in patients with end-stage renal disease (ESRD) undergoing

Sekisui will purchase substantially all of the assets of the business, including diagnostic product lines and technologies. The business will be operated as part of Sekisui Medical Co,

Stromedix said that the compound is the second Stromedix pipeline asset to be sourced from the laboratory of Dean Sheppard at University of California, San Francisco (UCSF). Preclinical

Prism Pharma said that the Nexterone Premixed injection is indicated for initiation of treatment and prophylaxis of frequently recurring ventricular fibrillation (VF) and hemodynamically unstable ventricular tachycardia (VT)

In the trial, all three doses of IPX066 showed improvement compared to placebo. Impax Pharma said that the mean sum of Parts II and III UPDRS score on

The new studies show that siRNAs designed to target a virus known to infect CHO cells – cells that are commonly used to produce recombinant proteins and monoclonal

The Court also found that NPWT products marketed by Smith & Nephew (SNN) infringe one of the patents. In June 2010, the High Court of Justice Chancery Division,